Literature DB >> 14555986

The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis.

Mario Mikula1, Josef Gotzmann, Alexandra N M Fischer, Markus F Wolschek, Christiane Thallinger, Rolf Schulte-Hermann, Hartmut Beug, Wolfgang Mikulits.   

Abstract

Hepatocytes adopt an invasive and metastatic phenotype caused by the cooperation of transforming growth factor (TGF)-beta and oncogenic Ha-Ras. In the initial phase of this process, c-Fos is rapidly induced by TGF-beta, but then decreases to undetectable levels. Here, we investigated the functional implications of c-Fos activation and its contribution to hepatocellular tumorigenesis. By employing conditional c-Fos expression, we observed that continuous activation of c-Fos and consequently AP-1 activity leads to depolarization of differentiated murine epithelial hepatocytes. Most remarkably, this change in morphology was associated with inhibition of proliferation and induction of cell death. Coexpression of antiapoptotic Bcl-XL or scavenging of reactive oxygen species was sufficient to prevent the c-Fos-mediated phenotype. In contrast, the cooperation of c-Fos with oncogenic Ha-Ras or a Ras mutant selectively activating the MAPK pathway even enhanced c-Fos-induced effects. Showing the negative role in hepatocellular tumorigenesis, c-Fos repressed oncogenic Ras-driven anchorage-independent growth in vitro and strongly suppressed tumour formation in vivo. Taken together, we demonstrate that c-Fos modulates plasticity of epithelial hepatocytes and acts tumour suppressive in neoplastic hepatocytes by stimulating cell cycle inhibition and cell death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14555986     DOI: 10.1038/sj.onc.1206781

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  23 in total

1.  Overexpression of aryl hydrocarbon receptor (AHR) signalling pathway in human meningioma.

Authors:  Noble Kumar Talari; Manas K Panigrahi; Sailaja Madigubba; Prakash Babu Phanithi
Journal:  J Neurooncol       Date:  2018-01-04       Impact factor: 4.130

Review 2.  Emerging roles of ATF2 and the dynamic AP1 network in cancer.

Authors:  Pablo Lopez-Bergami; Eric Lau; Ze'ev Ronai
Journal:  Nat Rev Cancer       Date:  2010-01       Impact factor: 60.716

3.  Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding.

Authors:  Cheng Ji; Ruty Mehrian-Shai; Christine Chan; Ya-Hsuan Hsu; Neil Kaplowitz
Journal:  Alcohol Clin Exp Res       Date:  2005-08       Impact factor: 3.455

4.  Noise exposure immediately activates cochlear mitogen-activated protein kinase signaling.

Authors:  Kumar N Alagramam; Ruben Stepanyan; Samson Jamesdaniel; Daniel H-C Chen; Rickie R Davis
Journal:  Noise Health       Date:  2014 Nov-Dec       Impact factor: 0.867

5.  Prognostic significance of loss of c-fos protein in gastric carcinoma.

Authors:  Seon Pil Jin; Ji Hun Kim; Min A Kim; Han-Kwang Yang; Hee Eun Lee; Hye Seung Lee; Woo Ho Kim
Journal:  Pathol Oncol Res       Date:  2007-12-25       Impact factor: 3.201

6.  Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin.

Authors:  Lihua Min; Yuan Ji; Latifa Bakiri; Zhixin Qiu; Jin Cen; Xiaotao Chen; Lingli Chen; Harald Scheuch; Hai Zheng; Lunxiu Qin; Kurt Zatloukal; Lijian Hui; Erwin F Wagner
Journal:  Nat Cell Biol       Date:  2012-10-07       Impact factor: 28.824

7.  Vanadium-induced apoptosis of HaCaT cells is mediated by c-fos and involves nuclear accumulation of clusterin.

Authors:  Soultana Markopoulou; Evangelos Kontargiris; Christina Batsi; Theodore Tzavaras; Ioannis Trougakos; David A Boothman; Efstathios S Gonos; Evangelos Kolettas
Journal:  FEBS J       Date:  2009-06-15       Impact factor: 5.542

Review 8.  Epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Franziska van Zijl; Gudrun Zulehner; Michaela Petz; Doris Schneller; Christoph Kornauth; Mara Hau; Georg Machat; Markus Grubinger; Heidemarie Huber; Wolfgang Mikulits
Journal:  Future Oncol       Date:  2009-10       Impact factor: 3.404

9.  Evidence for Homodimerization of the c-Fos Transcription Factor in Live Cells Revealed by Fluorescence Microscopy and Computer Modeling.

Authors:  Nikoletta Szalóki; Jan Wolfgang Krieger; István Komáromi; Katalin Tóth; György Vámosi
Journal:  Mol Cell Biol       Date:  2015-08-24       Impact factor: 4.272

10.  HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer).

Authors:  L Plowright; K J Harrington; H S Pandha; R Morgan
Journal:  Br J Cancer       Date:  2009-01-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.